Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol

Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol

Introduction Inhaled nitric oxide (iNO) use is recommended for persistent pulmonary hypertension of the newborn in term and late preterm infants. Recently, iNO therapy to prevent bronchopulmonary dysplasia (BPD) or rescue for hypoxic respiratory failure and pulmonary hypertension secondary to BPD ha...

Full description

Bibliographic Details
Main Authors: Hidehiko Nakanishi, Shin Kato, Erika Ota, Toshinori Nakashima, Sota Iwatani, Daichi Suzuki, Yohei Minamitani, Miku Hosokawa, Atsushi Nakao
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/2/e080298.full

Internet

https://bmjopen.bmj.com/content/14/2/e080298.full

Similar Items